Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
This study has been withdrawn prior to recruitment.
Study NCT00072540 Information provided by National Cancer Institute (NCI)
First Received: November 4, 2003 Last Updated: June 14, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage 0 Cervical Cancer
Additional conditions recognized in this trial
Cervical Intraepithelial Neoplasia
Uterine Cervical Dysplasia
More general conditions related to this trial
Carcinoma
Carcinoma in Situ
Genital Diseases, Female
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Precancerous Conditions
Uterine Cervical Diseases
Uterine Diseases
Interventions listed in this trial
celecoxib
anti-cytokine therapy
antiangiogenesis therapy
biological therapy
cancer prevention intervention
chemoprevention of cancer
enzyme inhibitor therapy
growth factor antagonist therapy
Additional drug interventions recognized in this trial
Enzyme Inhibitors
Mitogens
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Southwest Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
